ATE297950T1 - Testverfahren und reagenzien zur quantifizierung von hbnp - Google Patents

Testverfahren und reagenzien zur quantifizierung von hbnp

Info

Publication number
ATE297950T1
ATE297950T1 AT97907946T AT97907946T ATE297950T1 AT E297950 T1 ATE297950 T1 AT E297950T1 AT 97907946 T AT97907946 T AT 97907946T AT 97907946 T AT97907946 T AT 97907946T AT E297950 T1 ATE297950 T1 AT E297950T1
Authority
AT
Austria
Prior art keywords
hbnp
antibody
quantification
reagents
sample
Prior art date
Application number
AT97907946T
Other languages
English (en)
Inventor
Ronald P Mischak
Garret A Lim
Jan Marian Scardina
Original Assignee
Scios Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scios Inc filed Critical Scios Inc
Application granted granted Critical
Publication of ATE297950T1 publication Critical patent/ATE297950T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/58Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/839Nerves; brain
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/841Muscles; heart
AT97907946T 1996-03-04 1997-03-04 Testverfahren und reagenzien zur quantifizierung von hbnp ATE297950T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61017296A 1996-03-04 1996-03-04
PCT/US1997/003163 WO1997032900A1 (en) 1996-03-04 1997-03-04 ASSAY AND REAGENTS FOR QUANTIFYING hBNP

Publications (1)

Publication Number Publication Date
ATE297950T1 true ATE297950T1 (de) 2005-07-15

Family

ID=24443982

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97907946T ATE297950T1 (de) 1996-03-04 1997-03-04 Testverfahren und reagenzien zur quantifizierung von hbnp

Country Status (13)

Country Link
US (3) US6124430A (de)
EP (3) EP2292662B1 (de)
JP (3) JP4049816B2 (de)
AT (1) ATE297950T1 (de)
AU (1) AU1981597A (de)
CA (1) CA2248140C (de)
DE (1) DE69733560T2 (de)
DK (2) DK2292662T3 (de)
ES (1) ES2243979T3 (de)
HK (1) HK1078096A1 (de)
PT (2) PT2292662E (de)
WO (1) WO1997032900A1 (de)
ZA (1) ZA971864B (de)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2665850B2 (ja) * 1991-11-14 1997-10-22 塩野義製薬株式会社 hBNPのC端を認識するモノクロ−ナル抗体
US6379975B1 (en) * 1996-11-27 2002-04-30 T.A.C. Thrombosis And Coagulation Aktiebolag Methods and reagents for determining protein S
US6117644A (en) * 1998-06-04 2000-09-12 Ottawa Heart Institute Research Corporation Predicting and detecting cardiac allograft rejection
GB9827348D0 (en) * 1998-12-12 1999-02-03 Univ Leicester Natriuretic peptide
WO2000071576A2 (en) * 1999-05-24 2000-11-30 Mayo Foundation For Medical Education And Research Adenovirus vectors encoding brain natriuretic peptide
US6407211B1 (en) * 1999-12-17 2002-06-18 Mayo Foundation For Medical Education And Research Chimeric natriuretic peptides
US20060228364A1 (en) * 1999-12-24 2006-10-12 Genentech, Inc. Serum albumin binding peptides for tumor targeting
US20040253242A1 (en) * 2000-12-05 2004-12-16 Bowdish Katherine S. Rationally designed antibodies
CA2436671C (en) 2000-12-05 2015-02-03 Alexion Pharmaceuticals, Inc. Rationally designed antibodies
US7396917B2 (en) 2000-12-05 2008-07-08 Alexion Pharmaceuticals, Inc. Rationally designed antibodies
AU2002231008A1 (en) * 2000-12-19 2002-07-01 Instrumentation Laboratory Co. Free analyte detection system
US7632647B2 (en) * 2001-04-13 2009-12-15 Biosite Incorporated Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
US20030219734A1 (en) * 2001-04-13 2003-11-27 Biosite Incorporated Polypeptides related to natriuretic peptides and methods of their identification and use
US20030199000A1 (en) * 2001-08-20 2003-10-23 Valkirs Gunars E. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040176914A1 (en) * 2001-04-13 2004-09-09 Biosite Incorporated Methods and compositions for measuring biologically active natriuretic peptides and for improving their therapeutic potential
US7524635B2 (en) * 2003-04-17 2009-04-28 Biosite Incorporated Methods and compositions for measuring natriuretic peptides and uses thereof
ATE439588T1 (de) * 2001-05-04 2009-08-15 Biosite Inc Diagnostische marker für akute herzerkrankungen und verfahren des gebrauchs
US7608406B2 (en) * 2001-08-20 2009-10-27 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
EP1419388B1 (de) 2001-08-20 2009-10-07 Biosite Incorporated Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon
US20040209307A1 (en) * 2001-08-20 2004-10-21 Biosite Incorporated Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040219509A1 (en) * 2001-08-20 2004-11-04 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US6461828B1 (en) 2001-09-04 2002-10-08 Syn X Pharma Conjunctive analysis of biological marker expression for diagnosing organ failure
AUPS169202A0 (en) * 2002-04-11 2002-05-16 Goetze, Jens Peter Neuropeptide assay
FR2843396B1 (fr) * 2002-08-07 2005-04-15 Bio Rad Pasteur Anticorps specifiques pour le diagnostic de l'insuffisance cardiaque
GB0224425D0 (en) * 2002-10-21 2002-11-27 Univ Leicester Method for prediction of cardiac disease
AU2003285200A1 (en) * 2002-11-09 2004-06-03 Nobex Corporation Modified carbamate-containing prodrugs and methods of synthesizing same
US8263325B2 (en) * 2002-11-15 2012-09-11 Ottawa Heart Institute Research Corporation Predicting, detecting and monitoring treatment of cardiomyopathies and myocarditis
US6960472B2 (en) * 2002-11-18 2005-11-01 Ottawa Heart Institute Research Corporation Monoclonal antibodies against N-Terminus proBNP
DE60331584D1 (de) * 2002-11-26 2010-04-15 Biocon Ltd Modifizierte natriuretic verbindungen, konjugate und ihre verwendungen
US7648962B2 (en) * 2002-11-26 2010-01-19 Biocon Limited Natriuretic compounds, conjugates, and uses thereof
WO2004082639A2 (en) * 2003-03-19 2004-09-30 Baylor College Of Medicine Detecting coronary artery disease with bnp during stress testing
JP2006527190A (ja) * 2003-04-17 2006-11-30 サイファージェン バイオシステムズ インコーポレイテッド ナトリウム利尿ペプチドに関連したポリペプチド、並びにこれらの同定および使用法
WO2004105575A2 (en) * 2003-05-29 2004-12-09 Trustee Of Darmouth College A method for detecting cardiac ischemia via changes in b-natriuretic peptide levels
DK1638443T3 (da) * 2003-06-20 2011-02-07 Mayo Foundation Isoformer af hjerne-natriuretisk peptid
GB2403533A (en) 2003-06-30 2005-01-05 Orion Corp Atrial natriuretic peptide and brain natriuretic peptide and assays and uses thereof
US7291501B2 (en) * 2003-07-16 2007-11-06 Abbott Laboratories Stable compositions for measuring human natriuretic peptides
US7445933B2 (en) * 2003-07-16 2008-11-04 Abbott Laboratories, Inc. Stable calibrators or controls for measuring human natriuretic peptides
US7632234B2 (en) * 2003-08-29 2009-12-15 Medtronic, Inc. Implantable biosensor devices for monitoring cardiac marker molecules
KR20050062836A (ko) * 2003-12-18 2005-06-28 학교법인 대양학원 트랜스코딩 방법 및 장치
US20080207505A1 (en) * 2005-01-12 2008-08-28 James Kenneth D Bna Conjugates and Methods of Use
FR2863269B1 (fr) * 2005-01-14 2006-05-26 Bio Rad Pasteur Peptides specifiques pour le diagnostic de l'insuffisance cardiaque
US7731965B2 (en) * 2005-02-17 2010-06-08 Abbott Lab Human ring specific BNP antibodies
WO2007041645A2 (en) * 2005-10-03 2007-04-12 Scios Inc. Oxidized human bnp
JP5364378B2 (ja) * 2005-11-09 2013-12-11 アボット・ラボラトリーズ ヒトbnp免疫特異的抗体
US7939069B2 (en) * 2005-11-09 2011-05-10 Abbott Laboratories Human BNP immunospecific antibodies
WO2007115175A2 (en) 2006-03-30 2007-10-11 Palatin Technologies, Inc. Cyclic natriuretic peptide constructs
US8580746B2 (en) * 2006-03-30 2013-11-12 Palatin Technologies, Inc. Amide linkage cyclic natriuretic peptide constructs
AU2007233123A1 (en) * 2006-03-30 2007-10-11 Palatin Technologies, Inc. Linear natriuretic peptide constructs
WO2008021872A1 (en) 2006-08-08 2008-02-21 Mayo Foundation For Medical Education And Research Diuretic and natriuretic polypeptides
US20080064045A1 (en) 2006-09-07 2008-03-13 Huaiqin Wu Biomarker fragments for the detection of human BNP
JP4851367B2 (ja) * 2007-03-05 2012-01-11 富士フイルム株式会社 ローカルプラズモン増強蛍光センサ
AT504942B1 (de) 2007-03-07 2009-08-15 Biomedica Medizinprodukte Gmbh Verfahren zur bestimmung von probnp
EP2150811B1 (de) * 2007-05-08 2013-01-16 Abbott Laboratories Test für menschliches natriuretisches typ-b-peptid mit verminderter kreuzreaktivität mit anderen peptidformen
FR2919611B1 (fr) 2007-08-03 2009-10-23 Bio Rad Pasteur Sa Nouvel epitope du bnp (1-32) et anticorps diriges contre cet epitope
US8357656B2 (en) * 2007-09-15 2013-01-22 Mayo Foundation For Medical Education And Research Natriuretic peptide receptor-C agonists
EP2612868B1 (de) * 2007-11-01 2018-08-15 Astellas Pharma Inc. Immunsuppressive Polypeptide und Nucleinsäuren
WO2009086411A2 (en) * 2007-12-27 2009-07-09 Abbott Laboratories Negative mimic antibody for use as a blocking reagent in bnp immunoassays
US9482677B2 (en) * 2008-02-27 2016-11-01 Scios Inc. Method, composition and device for sampling natriuretic peptides in a biological fluid
US20090286329A1 (en) * 2008-05-19 2009-11-19 Abbott Laboratoires Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides
US20090286256A1 (en) * 2008-05-19 2009-11-19 Abbott Laboratories Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides
US8455212B2 (en) * 2009-11-21 2013-06-04 Abbott Laboratories Assays for human NT-pro B-type natriuretic peptide, human pro B-type natriuretic peptide and human B-type natriuretic peptide
JP5810514B2 (ja) * 2009-12-07 2015-11-11 東ソー株式会社 タグペプチド
US9127054B2 (en) 2010-12-09 2015-09-08 Toray Industries, Inc. Immunoassay of cofilin 1 protein
JP2012140331A (ja) * 2010-12-28 2012-07-26 Tosoh Corp タグペプチド
WO2013032784A1 (en) 2011-08-30 2013-03-07 Mayo Foundation For Medical Education And Research Natriuretic polypeptides
WO2013103896A1 (en) 2012-01-06 2013-07-11 Mayo Foundation For Medical Education And Research Treating cardiovascular or renal diseases
JP2014028770A (ja) * 2012-07-31 2014-02-13 Tosoh Corp ヒトb型ナトリウム利尿ペプチド特異抗体およびそれを用いた測定法
JP2014091719A (ja) * 2012-11-05 2014-05-19 Tosoh Corp ヒトb型ナトリウム利尿ペプチドの3−32位に相当するポリペプチドに対する特異抗体およびそれを用いた測定法
JP2015137272A (ja) * 2014-01-24 2015-07-30 東ソー株式会社 新規のペプチド及び疾患の検出方法
CN104569429B (zh) * 2015-01-04 2017-01-18 深圳市艾瑞生物科技有限公司 一种快速定量检测脑钠肽的均相荧光免疫试剂组及其制备方法
JP6772498B2 (ja) 2016-03-18 2020-10-21 株式会社Sumco 基板収納容器
EP3464339A4 (de) * 2016-06-03 2019-12-25 Cedars-Sinai Medical Center Proteolytischer test von b-typ-natriuretischem peptid zur beurteilung des risikos von herz-kreislauf-erkrankungen
US11193947B2 (en) 2016-06-03 2021-12-07 Cedars-Sinai Medical Center B-type natriuretic peptide proteolytic assay for cardiovascular disease risk assessment
CN112094338B (zh) * 2019-05-14 2022-03-25 深圳市亚辉龙生物科技股份有限公司 氨基末端脑钠肽前体多肽、偶联蛋白
CN113956355B (zh) * 2021-07-26 2023-06-23 无锡傲锐东源生物科技有限公司 抗人脑利钠肽(bnp)兔单克隆抗体及其应用
WO2023190560A1 (ja) * 2022-03-31 2023-10-05 デンカ株式会社 ヒトb型ナトリウム利尿ペプチド又はその前駆体若しくは分解物を検出するための方法、組成物、及びキット

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114923A (en) 1988-05-31 1992-05-19 California Biotechnology Inc. Recombinant techniques for production of novel natriuretic and vasodilator peptides
JP2676114B2 (ja) * 1990-04-16 1997-11-12 塩野義製薬株式会社 hBNPを認識するモノクローナル抗体および該抗体を用いるhBNPの免疫測定法
JPH05207891A (ja) * 1991-03-08 1993-08-20 Shionogi & Co Ltd 脳性ナトリウム利尿ペプチドの製造方法
JPH0556794A (ja) * 1991-09-03 1993-03-09 Dai Ichi Pure Chem Co Ltd 生理活性ペプチドの製造法
JPH0568581A (ja) * 1991-09-10 1993-03-23 Dai Ichi Pure Chem Co Ltd 生理活性ペプチドの製造法
JP2665850B2 (ja) * 1991-11-14 1997-10-22 塩野義製薬株式会社 hBNPのC端を認識するモノクロ−ナル抗体
DE4137730C2 (de) 1991-11-15 1993-10-21 Texas Instruments Deutschland In einer Halbleiterschaltung integrierte Schaltungsanordnung
GB9211686D0 (en) * 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds

Also Published As

Publication number Publication date
CA2248140A1 (en) 1997-09-12
ZA971864B (en) 1997-12-18
EP2292662A3 (de) 2011-07-13
DE69733560D1 (de) 2005-07-21
HK1078096A1 (en) 2006-03-03
DK2292662T3 (da) 2014-05-05
JP2007169293A (ja) 2007-07-05
US6124430A (en) 2000-09-26
DK0914344T3 (da) 2005-08-29
DE69733560T2 (de) 2006-05-11
AU1981597A (en) 1997-09-22
ES2243979T3 (es) 2005-12-01
EP0914344B1 (de) 2005-06-15
EP2292662B1 (de) 2014-04-23
EP0914344B8 (de) 2005-08-10
EP1557431B1 (de) 2012-08-15
JP2000507094A (ja) 2000-06-13
US6376207B1 (en) 2002-04-23
CA2248140C (en) 2005-02-01
PT914344E (pt) 2005-10-31
EP2292662A2 (de) 2011-03-09
PT2292662E (pt) 2014-07-16
US6162902A (en) 2000-12-19
JP2011102318A (ja) 2011-05-26
EP1557431A1 (de) 2005-07-27
JP4049816B2 (ja) 2008-02-20
WO1997032900A1 (en) 1997-09-12
EP0914344A1 (de) 1999-05-12

Similar Documents

Publication Publication Date Title
ATE297950T1 (de) Testverfahren und reagenzien zur quantifizierung von hbnp
ATE209356T1 (de) Ein verfahren zur bestimmung von kollagenfragmenten in körperflüssigkeiten, ein testkit und mittel zur durchführung des verfahrens, und seine verwendung zur feststellung von mit dem kollagenmetabolismus assoziierten störungen
EP0165681A3 (de) Verfahren zum Nachweis von drogeninduzierter Thrombozytopenia und in diesem Verfahren zu verwendender Immunosatz
DE59309900D1 (de) Verfahren zur Analyse partikelverstärkter Agglutinationsreaktionen auf Zentrifugalanalysatoren durch Bestimmung der Trübungsaufhellung
ATE112059T1 (de) Verfahren zur bestimmung eines analyten.
CA2235316A1 (en) A method for detecting antipolymer antibodies and a diagnostic test kit for use in aiding the diagnosis of silicone related diseases (srd)
KR890702039A (ko) 1,25-디하이드록시 비타민 d의 분석 방법
DE3850249D1 (de) Nachweis von analyt in partikel enthaltenden proben.
DE68924243T2 (de) Verfahren und Reagenzien zum Nachweis von Amphetamin und/oder d-Methamphetamin in biologischen Proben.
ATE80463T1 (de) Verfahren und testtraeger zur bestimmung eines analyten.
DE50110174D1 (de) Verfahren und testkit zum nachweis von analyten in einer probe
EP0387027A3 (de) Methode und Reagenz zur Diagnose von Endometriose
WO1998029726A3 (en) Method of detecting and determining the concentration of total troponin i in a biological sample
CA2213083A1 (en) Detection of antibody production
EP0368208A3 (de) Immunoassay-Verfahren und Testsatz dafür
MY106963A (en) Agglutination assay.
DE69026497D1 (de) Verfahren zur prüfung von d-vanillylmandelsäure und reagenz und satz dafür
ATE285075T1 (de) Detektion und quantifikation von vancomycin in den biologischen flüssigkeiten
DE59610859D1 (de) Immunologische Bestimmungsmethode
DE59906849D1 (de) Verfahren zum spezifischen Nachweis von glykosilierten Proteinen
ATE117727T1 (de) Verfahren zur bestimmung von isoenzymen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0914344

Country of ref document: EP